ORCID as entered in ROS

Select Publications
2022, 'COPPER CHELATION THERAPY TARGETS S-ADENOSYLMETHIONINE (SAM) METABOLISM AND EPIGENETIC REGULATORS IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, GERMANY, Hamburg, Vol. 24, pp. 22 - 22, presented at 20th International Symposium on Pediatric Neuro-Oncology (ISPNO) / Annual Meeting of the Brain-Tumor-Group-of-SIOP-Europe (SIOPE-BTG), GERMANY, Hamburg, 11 June 2022 - 15 June 2022
,2022, 'DIPG-06. Uncovering the FACTs in Diffuse Midline Glioma (DMG)', in Neuro-Oncology, Oxford University Press (OUP), Vol. 24, pp. i18 - i18, http://dx.doi.org/10.1093/neuonc/noac079.063
,2022, 'DIPG-20. Copper chelation therapy targets S-adenosylmethionine (SAM) metabolism and epigenetic regulators in diffuse intrinsic pontine glioma (DIPG)', in Neuro-Oncology, Oxford University Press (OUP), Vol. 24, pp. i22 - i22, http://dx.doi.org/10.1093/neuonc/noac079.077
,2022, 'UNCOVERING THE FACTS IN DIFFUSE MIDLINE GLIOMA (DMG)', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, Vol. 24, pp. 18 - 18, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000840122400065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Immunotherapy: IN VITRO STUDIES IN SUPPORT OF GD2-SPECIFIC CAR-T CELL THERAPY FOR AGGRESSIVE ADULT AND PEDIATRIC BRAIN TUMORS', in Cytotherapy, Elsevier BV, Vol. 24, pp. S125 - S125, http://dx.doi.org/10.1016/s1465-3249(22)00336-x
,2021, 'TARGETING FACILITATES CHROMATIN TRANSCRIPTION (FACT) AS A NOVEL STRATEGY THAT ENHANCES RESPONSE TO HISTONE DEACETYLASE (HDAC) INHIBITION IN DIPG', in NEURO-ONCOLOGY, OXFORD UNIV PRESS INC, Vol. 23, pp. 18 - 19, http://dx.doi.org/10.1093/neuonc/noab090.075
,2020, 'DDEL-12. NANOPARTICLE DELIVERY OF DOXORUBICIN FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)', in Neuro-Oncology, Oxford University Press (OUP), Vol. 22, pp. iii286 - iii286, http://dx.doi.org/10.1093/neuonc/noaa222.047
,2020, 'DIPG-27. TARGETING FACILITATES CHROMATIN TRANSCRIPTION (FACT) AS A NOVEL STRATEGY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) THAT ENHANCES RESPONSE TO HISTONE DEACETYLASE (HDAC) INHIBITION', in Neuro-Oncology, Oxford University Press (OUP), Vol. 22, pp. iii292 - iii292, http://dx.doi.org/10.1093/neuonc/noaa222.076
,2019, '[Cu-64]CuCl2 PET metallomics for determining the anticancer mechanism of novel drug Dextran-Catechin', in JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, WILEY, Vol. 62, pp. S526 - S527, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000468965200440&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Copper homeostasis: A new player in anti-tumor immune response', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 79, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), GA, Atlanta, 29 March 2019 - 03 April 2019, http://dx.doi.org/10.1158/1538-7445.SABCS18-3224
,2018, 'Harnessing copper in cancer to enhance anti-tumor immune response', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, SWITZERLAND, Geneva, Vol. 29, pp. 35 - 35, presented at ESMO Immuno-Oncology Congress, SWITZERLAND, Geneva, 13 December 2018 - 16 December 2018
,2017, 'Dextran-Catechin inhibits angiogenesis by disrupting copper homeostasis in endothelial cells', in Scientific Reports, Springer Nature, England, Vol. 7, pp. 7638, England, http://dx.doi.org/10.1038/s41598-017-07452-w
,2016, 'Imaging neuroblastoma xenograft using [Cu-64]CuCl2 for evaluation of novel treatment based on Dextran/Catechin conjugate', in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, SPRINGER, SPAIN, Barcelona, Vol. 43, pp. S480 - S480, presented at Annual Congress of the European-Association-of-Nuclear-Medicine, SPAIN, Barcelona, 15 October 2016 - 19 October 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000391802400670&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, Ageing impairs the airway epithelium defence response to SARS-CoV-2, http://dx.doi.org10.1101/2021.04.05.437453
,2024, CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers, http://dx.doi.org/10.21203/rs.3.rs-3957241/v1
,2023, A Near-Infrared Ratiometric Fluorescent Probe for Detecting Endogenous Cu2+ in the Brain, http://dx.doi.org/10.26434/chemrxiv-2023-mftg1
,2023, In vivofate of systemically administered encapsulin protein nanocages and implications for their use in targeted drug delivery, http://dx.doi.org/10.1101/2023.07.16.549228
,2022, A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer, http://dx.doi.org/10.1101/2022.09.16.508179
,2022, Copper chelation inhibits TGF-βpathways and suppresses epithelial-mesenchymal transition in cancer, http://dx.doi.org/10.1101/2022.10.03.510707
,2022, GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma, http://dx.doi.org/10.1101/2022.05.01.490250
,Dual Targeting of the Epigenome Via Facilitates Chromatin Transcription Complex (FACT) and Histone Deacetylase is a Potent Treatment Strategy for DIPG, http://dx.doi.org/10.2139/ssrn.3664176
,2023, Data from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, http://dx.doi.org/10.1158/0008-5472.c.6512334.v1
,2023, Data from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, http://dx.doi.org/10.1158/0008-5472.c.6512334
,2023, Figure S1 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, http://dx.doi.org/10.1158/0008-5472.22426440.v1
,2023, Figure S1 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, http://dx.doi.org/10.1158/0008-5472.22426440
,2023, Figure S2 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, http://dx.doi.org/10.1158/0008-5472.22426437
,2023, Figure S2 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, http://dx.doi.org/10.1158/0008-5472.22426437.v1
,2023, Figure S3 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, http://dx.doi.org/10.1158/0008-5472.22426434.v1
,2023, Figure S3 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, http://dx.doi.org/10.1158/0008-5472.22426434
,2023, Figure S4 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, http://dx.doi.org/10.1158/0008-5472.22426431
,2023, Figure S4 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, http://dx.doi.org/10.1158/0008-5472.22426431.v1
,2023, Figure S5 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, http://dx.doi.org/10.1158/0008-5472.22426428
,2023, Figure S5 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, http://dx.doi.org/10.1158/0008-5472.22426428.v1
,2023, Figure S6 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, http://dx.doi.org/10.1158/0008-5472.22426425
,2023, Figure S6 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, http://dx.doi.org/10.1158/0008-5472.22426425.v1
,2023, Figure S7 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, http://dx.doi.org/10.1158/0008-5472.22426422
,2023, Figure S7 from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, http://dx.doi.org/10.1158/0008-5472.22426422.v1
,2023, Master Regulator Analysis from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, http://dx.doi.org/10.1158/0008-5472.22426419.v1
,2023, Master Regulator Analysis from Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion, http://dx.doi.org/10.1158/0008-5472.22426419
,